Inactivation of the CovR/S virulence regulator impairs infection in an improved murine model of Streptococcus pyogenes naso-pharyngeal infection
- PMID: 23637876
- PMCID: PMC3636223
- DOI: 10.1371/journal.pone.0061655
Inactivation of the CovR/S virulence regulator impairs infection in an improved murine model of Streptococcus pyogenes naso-pharyngeal infection
Erratum in
- PLoS One. 2013;8(9):doi/10.1371/annotation/1144e132-9e69-47bb-8e65-1414dbb01db7
Abstract
Streptococcus pyogenes is a leading cause of pharyngeal infection, with an estimated 616 million cases per year. The human nasopharynx represents the major reservoir for all S. pyogenes infection, including severe invasive disease. To investigate bacterial and host factors that influence S. pyogenes infection, we have devised an improved murine model of nasopharyngeal colonization, with an optimized dosing volume to avoid fulminant infections and a sensitive host strain. In addition we have utilized a refined technique for longitudinal monitoring of bacterial burden that is non-invasive thereby reducing the numbers of animals required. The model was used to demonstrate that the two component regulatory system, CovR/S, is required for optimum infection and transmission from the nasopharynx. There is a fitness cost conferred by covR/S mutation that is specific to the nasopharynx. This may explain why S. pyogenes with altered covR/S have not become prevalent in community infections despite possessing a selective advantage in invasive infection.
Conflict of interest statement
Figures
References
-
- Carapetis JR, Steer AC, Mulholland EK, Weber M (2005) The global burden of group A streptococcal diseases. Lancet Infect Dis 5: 685–694. - PubMed
-
- Wiles S, Hanage WP, Frankel G, Robertson BD (2006) Modelling infectious disease–time to think outside the box? Nature Rev Microbiol 4: 307–312. - PubMed
-
- Hillenius WJ (1992) The evolution of nasal turbinates and mammalian endothermy. Paleobiology 18: 17–29.
-
- Slípka J (1988) Palatine tonsils–their evolution and ontogeny. Acta Oto-Laryngol 454: 18–22. - PubMed
-
- Wu HY, Nguyen H, Russell MW (1997) Nasal lymphoid tissue (NALT) as a mucosal immune inductive site. Scand J Immunol 46: 506–513. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- BB/E52708X/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- G0800720/1/NC3RS_/National Centre for the Replacement, Refinement and Reduction of Animals in Research/United Kingdom
- G0800777/MRC_/Medical Research Council/United Kingdom
- DDDH.PS0618/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
